|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0018801,
umls-concept:C0018802,
umls-concept:C0019993,
umls-concept:C0025859,
umls-concept:C0026565,
umls-concept:C0030705,
umls-concept:C0031206,
umls-concept:C0034656,
umls-concept:C0439810,
umls-concept:C0814861,
umls-concept:C1257890,
umls-concept:C1280500,
umls-concept:C2603343
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2000-3-16
|
|
pubmed:abstractText |
Results from recent studies on the effects of beta1-blockade in patients with heart failure demonstrated a 34% reduction in total mortality. However, the effect of beta1-blockade on the frequency of hospitalizations, symptoms, and quality of life in patients with heart failure has not been fully explored.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0098-7484
|
|
pubmed:author |
pubmed-author:AldershvileJJ,
pubmed-author:BalkRR,
pubmed-author:DeedwaniaPP,
pubmed-author:DietzRR,
pubmed-author:DunselmanP HPH,
pubmed-author:El AllafDD,
pubmed-author:FagerbergBB,
pubmed-author:GoldsteinSS,
pubmed-author:GottliebSS,
pubmed-author:GullestadLL,
pubmed-author:HalinenMM,
pubmed-author:HerlitzJJ,
pubmed-author:HjalmarsonAA,
pubmed-author:JánosiAA,
pubmed-author:KjekshusJJ,
pubmed-author:KuchJJ,
pubmed-author:NeuhausK LKL,
pubmed-author:RickenbacherPP,
pubmed-author:ThorgeirssonGG,
pubmed-author:VítovecJJ,
pubmed-author:WaagsteinFF,
pubmed-author:WedelHH,
pubmed-author:WikstrandJJ
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
8
|
|
pubmed:volume |
283
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1295-302
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10714728-Adrenergic beta-Antagonists,
pubmed-meshheading:10714728-Delayed-Action Preparations,
pubmed-meshheading:10714728-Double-Blind Method,
pubmed-meshheading:10714728-Female,
pubmed-meshheading:10714728-Heart Failure,
pubmed-meshheading:10714728-Hospitalization,
pubmed-meshheading:10714728-Humans,
pubmed-meshheading:10714728-Male,
pubmed-meshheading:10714728-Metoprolol,
pubmed-meshheading:10714728-Middle Aged,
pubmed-meshheading:10714728-Proportional Hazards Models,
pubmed-meshheading:10714728-Quality of Life,
pubmed-meshheading:10714728-Survival Analysis,
pubmed-meshheading:10714728-Treatment Outcome
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.
|
|
pubmed:affiliation |
Department of Cardiology, Sahlgrenska University Hospital, Göteborg, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
